WallStreetZenWallStreetZen

NYSE: ENFN
Enfusion Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$10.56-0.09 (-0.85%)
Updated Dec 12, 2024
ENFN Price
$10.56
Fair Value Price
N/A
Market Cap
$1.36B
52 Week Low
$7.52
52 Week High
$10.75
P/E
264x
P/B
19.42x
P/S
4.52x
PEG
3.42x
Dividend Yield
N/A
Revenue
$195.16M
Earnings
$3.33M
Gross Margin
67.2%
Operating Margin
2.13%
Profit Margin
1.7%
Debt to Equity
0.55
Operating Cash Flow
$32M
Beta
1.25
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ENFN Overview

Enfusion, Inc. provides SaaS solutions to the investment management industry in the U.S. and internationally. Its offerings enable investment managers to make investment decisions in real-time. Functionalites includes a Portfolio Management System, an Order and Execution Management System, an Accounting/General Ledger System, and the Enfusion Analytics System. Enfusion was incorporated in 2021 and is headquartered in Chicago, IL.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ENFN's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More

Zen Rating Component Grades

C
Value
B
Growth
C
Momentum
D
Sentiment
B
Safety
A
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: App

Industry Rating
B
ENFN
Ranked#41 of 206

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Research Solutions (RSSS)
$3.86A
Viant Technology (DSP)
$20.97A
Wm Technology (MAPS)
$1.35A
View Top App Stocks

Be the first to know about important ENFN news, forecast changes, insider trades & much more!

ENFN News

Overview

Due Diligence Score

–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ENFN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ENFN ($10.56) is trading above its intrinsic value of $1.31, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ENFN is poor value based on its earnings relative to its share price (264x), compared to the US market average (29.87x)
P/E vs Market Valuation
ENFN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ENFN due diligence checks available for Premium users.

Valuation

ENFN price to earnings (PE)

For valuing profitable companies with steady earnings

Company
264x
Industry
36.59x
Market
29.87x
ENFN is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ENFN is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

ENFN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
19.42x
Industry
8.16x
ENFN is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ENFN price to earnings growth (PEG)

For valuing profitable companies with growth potential

ENFN is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

ENFN's financial health

Profit margin

Revenue
$51.2M
Net Income
$1.4M
Profit Margin
2.8%
ENFN's Earnings (EBIT) of $4.15M... subscribe to Premium to read more.
Interest Coverage Financials
ENFN's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$134.9M
Liabilities
$38.8M
Debt to equity
0.55
ENFN's short-term assets ($85.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ENFN's short-term assets ($85.44M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ENFN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$16.2M
Investing
-$2.8M
Financing
-$14.0k
ENFN's operating cash flow ($31.60M)... subscribe to Premium to read more.
Debt Coverage Financials

ENFN vs App Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ENFNB$1.36B-0.85%264.00x19.42x
BMBLC$1.32B-2.70%-1.69x1.55x
DSPA$1.32B-0.33%299.57x22.18x
BLNDC$1.30B-1.93%-14.94x-26.21x
AMPLB$1.45B+0.89%-17.26x5.01x
View Top App Stocks

Enfusion Stock FAQ

What is Enfusion's quote symbol?

(NYSE: ENFN) Enfusion trades on the NYSE under the ticker symbol ENFN. Enfusion stock quotes can also be displayed as NYSE: ENFN.

If you're new to stock investing, here's how to buy Enfusion stock.

What is the 52 week high and low for Enfusion (NYSE: ENFN)?

(NYSE: ENFN) Enfusion's 52-week high was $10.75, and its 52-week low was $7.52. It is currently -1.72% from its 52-week high and 40.43% from its 52-week low.

How much is Enfusion stock worth today?

(NYSE: ENFN) Enfusion currently has 128,570,838 outstanding shares. With Enfusion stock trading at $10.56 per share, the total value of Enfusion stock (market capitalization) is $1.36B.

Enfusion stock was originally listed at a price of $19.81 in Oct 21, 2021. If you had invested in Enfusion stock at $19.81, your return over the last 3 years would have been -46.69%, for an annualized return of -18.92% (not including any dividends or dividend reinvestments).

How much is Enfusion's stock price per share?

(NYSE: ENFN) Enfusion stock price per share is $10.56 today (as of Dec 12, 2024).

What is Enfusion's Market Cap?

(NYSE: ENFN) Enfusion's market cap is $1.36B, as of Dec 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Enfusion's market cap is calculated by multiplying ENFN's current stock price of $10.56 by ENFN's total outstanding shares of 128,570,838.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.